ISSN 1300-4948 | E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Determination of intracellular Th1/Th2 type cytokines in lymphocytes of chronic hepatitis B patients treated with interferon-alpha
(Turk J Gastroenterol 2010; 21: 401-410)
DOI: 10.4318/tjg.2010.0127
Effects of Giardia lamblia infestation on the clinical sourse of cronic hepatitis B
(Turk J Gastroenterol 1998; 9: 24-27)
Acral erythema induced bu interferon alpha in a child
(Turk J Gastroenterol 1998; 9: 70-72)
Effect of anti-HCV positifity on response to hepatitis B virus vaccine in haemodialysis patients
(Turk J Gastroenterol 1998; 9: 105-107)
The prevalence of hepatocellular carcinoma in patients with liver cirrhosis in Southeastern Turkey
(Turk J Gastroenterol 1998; 9: 217-220)
Lamivudine resistance in untreated chronic hepatitis B patients in Turkey
(Turk J Gastroenterol 2008; 19: 99-103)
The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: An analysis of clinical studies
(Turk J Gastroenterol 2006; 17: 25-34)
An asymptomatic huge hepatocellular carcinoma with intra-atrial tumor thrombus in a patient with chronic hepatitis B viral infection
(Turk J Gastroenterol 2006; 17: 203-205)
Assessment of bone metabolism and mineral density in chronic viral hepatitis
(Turk J Gastroenterol 2006; 17: 260-266)
Hepatitis B and C virus in West-Central Turkey: Seroprevalence in healthy individuals admitted to a university hospital for routine health checks
(Turk J Gastroenterol 2006; 17: 267-272)
P21 expression and its relation to disease activity and hepatocyte proliferation in chronic hepatitis B virus infection
(Turk J Gastroenterol 2005; 16: 12-16)
Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey
(Turk J Gastroenterol 2005; 16: 183-187)
Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children
(Turk J Gastroenterol 2005; 16: 188-193)
Effect of interferon treatment on glucose metabolism in children with chronic hepatitis B infection
(Turk J Gastroenterol 2004; 15: 4-10)
Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: A prospective epidemiologic study
(Turk J Gastroenterol 2004; 15: 11-13)
A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels
(Turk J Gastroenterol 2004; 15: 14-20)
Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha
(Turk J Gastroenterol 2004; 15: 213-218)
Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C
(Turk J Gastroenterol 2001; 12: 89-94)
Hepatitis B seroprevalance and risk factors in urban areas of Malatya
(Turk J Gastroenterol 2002; 13: 1-5)
The effect of recombinant hepatitis B vaccine therapy in chronic hepatitis B infection
(Turk J Gastroenterol 2002; 13: 6-10)
Alanine aminotransferase deficiency in a hepatitis B surface antigen positive patient presenting with acute hepatitis
(Turk J Gastroenterol 2002; 13: 60-62)
Clinicopathologic features and risk factors for hepatocellular carcinoma: Results from a single center in southern Turkey
(Turk J Gastroenterol 2003; 14: 85-90)
Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: Clinical significance and correlation with serological markers
(Turk J Gastroenterol 2003; 14: 157-163)
A comparative immunohistochemical study of HBsAg, HBcAg and CD57 in chronic hepatitis B pediatric patients with and without malignant disorders
(Turk J Gastroenterol 2003; 14: 234-238)
Seroepidemiology of delta hepatitis in Turkey
(Turk J Gastroenterol 1999; 10: 316-327)
Evaluation of the outcome of interferon therapy in chronic hepatitis B infection
(Turk J Gastroenterol 1999; 10: -)
Autoantibodies in chronic viral hepatitis and autoimmune hepatitis
(Turk J Gastroenterol 1997; 8: 381-384)
Response to hepatitis B vaccine in patients with non-hepatitis B chronic liver disease
(Turk J Gastroenterol 1997; 8: 148-151)
Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study
(Turk J Gastroenterol 2009; 20: 27-30)
Relationship between serum levels of interleukin-10, interleukin-2 and soluble intercellular adhesion molecule-I and liver injury in chronic hepatitis B virus infection
(Turk J Gastroenterol 1999; 10: 243-248)
Review
Emerging therapeutics and relevant targets for chronic Hepatitis B
(Turk J Gastroenterol 2016; 27: 210-215)
DOI: 10.5152/tjg.2016.15521
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report
(Turk J Gastroenterol 2018; 29: 259-269)
DOI: 10.5152/tjg.2018.18263
Case Report
A case of gynecomastia due to entecavir
(Turk J Gastroenterol 2010; 21: 313-316)
DOI: 10.4318/tjg.2010.0108
A case of entecavir resistance which is developed after complete viral suppression during entecavir treatment for nucleoside-naive chronic hepatitis B
(Turk J Gastroenterol 2014; 25: 206-209)
DOI: 10.5152/tjg.2014.3605
Gastric cancer after cadaveric liver transplantation in a patient with autoimmune hepatitis: A case report and review of the literature
(Turk J Gastroenterol 2011; 22: 73-76)
DOI: 10.4318/tjg.2011.0160
Original Article
Prevelance of hepatitis D co-enfection in children with hepatitis B infection: Cross-sectional analyses from Western Turkey
(Turk J Gastroenterol 2013; 24: 345-348)
DOI: 10.4318/tjg.2013.0681
AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 353-358)
DOI: 10.4318/tjg.2012.0348
Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 247-252)
DOI: 10.4318/tjg.2012.0380
Gallstones in liver transplant recipients: A single-center study in China
(Turk J Gastroenterol 2015; 26: 429-434)
DOI: 10.5152/tjg.2014.6344
Characteristics of patients dying from acute viral hepatitis in Serbia
(Turk J Gastroenterol 2011; 22: 152-157)
DOI: 10.4318/tjg.2011.0184
Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection
(Turk J Gastroenterol 2014; 25: 142-146)
DOI: 10.5152/tjg.2014.5711
Responsiveness of children with celiac disease to different hepatitis B vaccination protocols
(Turk J Gastroenterol 2011; 22: 27-31)
DOI: 10.4318/tjg.2011.0152
The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B
(Turk J Gastroenterol 2015; 26: 36-41)
DOI: 10.5152/tjg.2015.4636
Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir
(Turk J Gastroenterol 2016; 27: 42-46)
DOI: 10.5152/tjg.2015.150348
Public awareness of hepatitis B infection in Turkey as a model of universal effectiveness in health care policy
(Turk J Gastroenterol 2014; 25: 304-308)
DOI: 10.5152/tjg.2014.6718
Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis B
(Turk J Gastroenterol 2016; 27: 279-283)
DOI: 10.5152/tjg.2016.16085
Quick Look to Guidelines
Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines
(Turk J Gastroenterol 2017; 28: 518-521)
DOI: 10.5152/tjg.2017.171017
Liver - Original Article
Role of nucleoside/nucleotide analogues and low-dose hepatitis B immune globulin in prophylaxis of hepatitis B recurrence among cadaveric liver transplant recipients
(Turk J Gastroenterol 2018; 29: 61-66)
DOI: 10.5152/tjg.2018.17595
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2018 Turkish Society of Gastroenterology | Latest Update: 29.06.2018